Author

N. M. Kanaan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. A. Desai· 1 shared A. J. Samelson· 1 shared C. Jerez· 1 shared C. Parra Bravo· 1 shared D. Eisenberg· 1 shared D. Goodness· 1 shared D. L. Swaney· 1 shared D. R. Southworth· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. A. Desai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJul 4, 2023

Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils

A. A. Desai, J. M. Zupancic, H. Trzeciakiewicz…·P. M. Tessier

This paper describes a FACS method using quantum dots to isolate high-quality conformational antibodies against insoluble antigens like amyloid fibrils.

DOI 10.1101/2023.07.04.547698

humanflow cytometry

𝕏 PostBluesky

Cell BiologybioRxivJun 16, 2023

CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis

A. J. Samelson, N. Ariqat, J. McKetney…·M. Kampmann

The paper uses CRISPR screens in iPSC-derived neurons to identify factors controlling tau aggregation, finding new pathways and potential therapeutic targets for tauopathies.

DOI 10.1016/j.cell.2025.12.038

humangenetic perturbation / CRISPR

𝕏 PostBluesky